Connect with us

A List of the Top Penny Stocks That Went Big

Some of the biggest industry players came from penny stocks that went big. So, what penny stocks became today’s industry leaders?
The post A List of the…

Published

on

Some of the biggest industry players came from penny stocks that went big. If you know what you’re doing with these stocks, you can make a lot of money. However, penny stocks come with a lot of risks and aren’t suitable for everyone.

However, if you can buy and hold through market volatility and recessions, there’s value in learning about penny stocks. Furthermore, you could be one of the early investors in what could be a major company in the future.

What are the Penny Stocks That Went Big?

What makes a ‘successful’ penny stock? Let’s dig in…

A penny stock is any stock that trades under $5 per share. These companies usually come with high volatility and low market capitalization. Although, the shares of many billion-dollar companies once traded for less than $5 per share, including some FAANG companies.

In recent years, there haven’t been many penny stock companies that went big. Although, it does happen. Penny stocks are typically backed by speculative companies that don’t have as much transparency or liquidity. And this makes them easier targets for “pump and dump” schemes. Certain traders can try boosting the price of a stock so that they can sell it at a huge profit while leaving the rest of investors behind. Despite this, some penny stocks succeed in becoming long-term winners, often due to certain milestones or the success of a product.

Nevertheless, remember that a successful company takes years to build. It might be true that the companies below are success stories, but they took many years in the making.

Some of the names on this list will surely make you wish you’d bought some shares when these companies traded at penny stock prices.

That said, let’s look at some of the penny stocks that went big. Furthermore, I’ll explain their success stories over the years…

Amazon (Nasdaq: AMZN)

Few people associate Amazon with penny stocks. However, Amazon itself was once traded at low prices.

The company has split its stock three times since its IPO. After going public at $18 per share on May 15, 1997, the company split its stock…

  • 2-1 basis on June 2, 1998
  • 3-1 basis on January 5, 1999
  • 2-1 basis on September 1, 1999

To be clear, Amazon stock was never technically a penny stock. However, with later stock-splits being accounted for, Amazon stock-would have traded for $1.73 per share following its public debut.

Taking the effects of splits into account, if you paid $18 per share for Amazon at its IPO, your shares would now be worth over $42,000 each. After all, this company is one of the most successful penny stocks in history.

Ford Motor Company (NYSE: F)

Ford is worth close to $55 billion today. However, the company is easy to invest in, with shares only trading at around $14 per share as of May 2022.

Although it has a price near penny stock territory, Ford is one of the most well-known car companies worldwide. So, why is Ford stock so cheap?

Ford stock’s performance over the years looks like a rollercoaster. Moreover, auto stocks are heavily influenced by the market and economy. During economic recessions, demand for vehicles drops… A lot.

As a result of the 2008 recession, Ford’s stock price fell to a staggering $1.80 per share. The stock recovered and was somewhat stable for a few years. However, during the pandemic-driven bear market of early 2020, the stock fell below $5 per share once again.

This stock is somewhat volatile and tends to crash when the market does. However, thanks to a recovering economy and Ford’s move into the electric vehicle market, this company’s long-term stock forecast looks promising.

GameStop (NYSE: GME)

In 2021, GameStop was the big story. The stock was worth around $4 in 2020, but prices soared in 2021. Moreover, this turnaround showed the power that individual investors can have over a stock.

The proof is in the numbers – at one point in 2021, GME stock traded for around $325. In just a year, the stock faced a staggering increase of around 8,000%. No, that’s not a typo. It’s the effect of your average Joe investors working together to surge a stock – with the help of Reddit. You can learn more about what happened with GameStop stock here.

GameStop stock has dropped since the staggering surge. As of May 2022, the stock trades at around $114. However, there’s a valuable lesson here.

Volume is always a positive factor in penny stocks. A penny stock with spikes in trading volume and social buzz often indicates a bright future. As a result, it’s become more common to see retail traders working together to turn penny stocks into multibaggers.

After all, it turned GameStop into one of the penny stocks that went big. You can look at Gamestop’s stock forecast and predictions here.

Advanced Micro Devices (Nasdaq: AMD)

You may not be familiar with this company. However, this company has affected you if you’ve ever bought a computer. In fact, this semiconductor stock is a major rival of Intel. And this rivalry is nearly as old as the semiconductor industry itself.

For many years, AMD has been a flea in Intel’s ear. However, it has now grown to be much more.

In January 2021, for the first time in 15 years, AMD overtook Intel in desktop central processing unit (CPU) market share. This figure is according to the PassMark CPU usage data chart and represents AMD with 50.8% of the market vs. 49.2% for Intel.

This is the first time AMD stands ahead of Intel since back in Q1 2006. This presents a unique opportunity for this penny stock that went big. Moreover, continuing trends indicate AMD’s share price isn’t likely to return to its mid-2016 levels when it traded at around $5. AMD stock currently trades for around $95.

Plug Power (Nasdaq: PLUG)

For those unfamiliar, Plug Power is at the forefront of the hydrogen fuel cell market.

This company has been a penny stock for more than a decade. However, it didn’t start this way. PLUG stock began trading in 1999 for $15 per share and grew to $150 per share by March 2000. Or, $1,500 per share in today’s shares. I’ll explain this below.

In May 2011, Plug Power effected a 10-for-1 reverse stock split. Following the IPO, the company’s stock tanked, going lower and lower before reaching an all-time low of an adjusted $2.45 per share in May 2011. As a result, the company resorted to a reverse stock split to maintain its listing on the Nasdaq exchange.

Since the reverse stock split, the company’s stock performance is volatile… and that’s an understatement. This stock is not for the risk-averse. It has a long history of ups and downs – with a lot of emphasis on downs.

Although, the stock has picked up in recent years as a result of renewed interest in the hydrogen market. The stock broke penny stock status in June 2020 and ran up to $67 by early 2021. Although, this was short-lived after Plug announced it would restate its financial results going back to 2018 following accounting errors.

The company has faced several spikes and drops since then. It currently trades at around $18 per share. Moreover, Plug Power stock is a striking example of the volatility that can come with penny stocks. Moreover, it stresses the importance of doing your research before investing.

The Final Line on Penny Stocks That Went Big

After looking at penny stocks that went big, some of today’s current penny stocks may look promising. Although, these stocks are generally high-risk securities with low market caps for a reason.

There’s value in learning about these stocks. After all, these companies didn’t get to where they are today without the help of retail investors. And it took years and major catalysts to reach the scale they’re at.

Moreover, these companies went big, but this isn’t the case for most penny stocks. Investing in penny stocks is a gamble. Some of these companies could go big. However, most won’t. So, it’s important to do your research before investing.

If you play your cards right, today’s penny stock could be an industry giant in ten years. For the risk-hungry investor, this could reap massive rewards. But returns are never guaranteed, and this is especially true for penny stocks.

The post A List of the Top Penny Stocks That Went Big appeared first on Investment U.

Read More

Continue Reading

Government

Steps to building a more patient-centric industry

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in
The post Steps to building…

Published

on

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine. In 2021, a CISCRIP Perceptions and Insights Study reported more disruption to daily routines compared to previous years, citing length of visits, travel, and diagnostic tests as top burdens.

To ease this burden, the life sciences industry has been searching for ways to make clinical trials more accessible for patients and to drive participation numbers, increase participant diversity, and improve overall patient experience. For many patients, this change starts with choice.

A recent survey of clinical trial professionals found that more than two-thirds of respondents (61%) believe giving patients choice will have a positive impact on clinical research, and well over half (58%) said that their organisations plan to give patients the option to choose how they participate in clinical trials moving forward. Some examples of these choices can include video visits, phone visits, and remote monitoring.

As the industry focuses on creating a more holistic, inclusive patient experience, here are key steps to consider in order to help bridge the gap between clinical research and the patient experience.

Build a base in the community

According to the FDA’s 2020 Drug Trials Snapshot Report, only 8% of clinical trial participants are Black or African American, as compared to nearly 14% of the US population. The fact is, many minorities never learn about vital clinical trials in play, or that they’re eligible to participate. Subsequently, they are excluded, creating an evident gap in participants, and subsequently needed data on how treatments respond across different demographics of people.

Creating a broader, more inclusive patient experience starts with building a network of advocates who can help organisers meet patients where they are located and educate them about the availability and value of the trials. Initially, there needs to be a more proactive and sustained nationwide outreach effort to raise clinical trial awareness within minority communities.

It’s also important to partner with trusted people within minority communities, such as religious and government leaders that have the credibility needed to share clinical trial information to counter scepticism. If sponsors can partner with patient-advocacy groups to inform design, recruitment, follow-up, and even data collection (particularly for patient-reported outcomes), it will help to keep patients engaged longer and potentially derive higher quality data sets that can lead to better patient outcomes over the long run.

Embrace technology to expand reach

Technology – especially related to automation and the cloud – can help create a more flexible clinical trial model, thereby making it easier for patients to participate. Digital tools used in decentralised trials, remote enrolment tools, consent forms, wearables, and remote devices, as well as data capture, can help to expand overall access to clinical trials. For example, with remote monitoring, doctors and trial administrators can analyse all the data coming in and, if there’s a problem, they can act more quickly and respond back to the patient through a mobile device such as a smartphone.

Cloud platforms can open two-way communication channels for patients, doctors, and trial administrators to talk and share data, essentially in real-time. Some early examples of these capabilities were part of the US Centers for Disease Control and Prevention’s (CDC) v-safe program, developed by Oracle, which is used to track the effects of the COVID-19 vaccines through voluntary, scheduled survey prompts, and to remind people about boosters. Today, capabilities like this are being extended so that trial data from wearable devices and home-monitoring systems can be communicated directly to trial sites.

A new solution

One significant roadblock to clinical trial inclusion of minority groups has been location and transportation. Many potential participants lack transportation to and from clinical sites, and some trials are only held in large city hospitals, instead of smaller community hospitals that participants can sometimes access more easily. Thanks to decentralised trials and technology that collects data remotely, people from anywhere can participate.

One approach the industry has been exploring is to utilise community retail pharmacies as a central location for people to learn about and participate in clinical trials. By collaborating with pharmacy retailers, sponsors will have more opportunities for patient recruitment because they can offer patients the convenience and comfort of visiting familiar community sites.

For example, CVS and Walgreens have instituted flexible clinical trial models that combine patient insights, technology capabilities, and in-person and virtual-care options to engage broader and more diverse communities. The result is a much more expansive pool of participants and potentially much better information about populations where the drug is effective, and other populations where it might not be effective.

Keep it simple

There’s a notion that because the healthcare and life sciences industries are very complex, the systems that support them have to be equally complex. In fact, the opposite is true. Easier-to-use systems will increase participation rates, and we will have better outcomes as a result. With so many technology advancements at its disposal, the industry must find a way to bridge the divide between patient experience and clinical research. The patient journey must be a positive one, so that they will encourage others to participate.

Imagine, clinical research as an accessible care option to anyone. Technology has given us the opportunity to make this goal a reality. But as an industry, we must innovate to bring new experiences to market and improve the clinical research ecosystem for patients, healthcare professionals, sponsors, and regulators.

About the author

Katherine (Kathy) Vandebelt is global head of clinical innovation at Oracle Health Sciences. With over thirty years of experience in clinical research working in different geographies and across various TA, Kathy has worked with various organisations to advance their clinical operations and business processes to a better operating model. She believes patients are the most important constituent in clinical development and provide the necessary information to assess the safety and efficacy of new medicines. She strives to introduce new experiences and make the clinical research ecosystem better for patients, healthcare professionals, sponsors, and regulators using the power of technology.

The post Steps to building a more patient-centric industry appeared first on .

Read More

Continue Reading

Uncategorized

Meta ‘powering through’ with Metaverse plans despite doubts — Zuckerberg

Billions of dollars have been poured into Meta’s virtual world with little return on investment, but CEO Mark Zuckerberg says he is holding fast.

Published

on

Billions of dollars have been poured into Meta’s virtual world with little return on investment, but CEO Mark Zuckerberg says he is holding fast.

Meta CEO Mark Zuckerberg is still hopeful about the company’s Metaverse plans regardless of the billions of dollars it’s sucking up from the company, claiming “someone has to build that.”

Appearing remotely for an interview at the Nov. 30 DealBook Summit in New York, Zuckerberg was asked his thoughts on whether the tech giants’ Metaverse play was still viable given its cost and the doubts cast over the platform, answering:

“I think things look very different on a ten-year time horizon than the zone that we're in for the next few years [...] I'm still completely optimistic about all the things that we've been optimistic about.”

He added part of “seeing things through” in the longer term was “powering through” the doubts held about its ambitions.

Meta's latest earnings, released on Oct. 26, revealed the largest-ever quarterly loss in its metaverse-building arm Reality Labs dating back to the fourth quarter of 2020. Zuckerberg’s virtual reality has cost $9.44 billion in 2022, closing in on the over $10 billion in losses recorded for 2021.

On the earnings call at the time Zuckerberg was unfazed by the cost, calling its metaverse the “next computing platform.” He doubled down on this claim at DealBook:

“We're not going to be here in the 2030s communicating and using computing devices that are exactly the same as what we have today, and someone has to build that and invest in it and believe in it.”

However, Zuckerberg admitted that the plans have come at a cost, Meta had to lay off 11,000 employees on Nov. 9 and the CEO said it had “planned out massive investments,” including into hardware to support its metaverse.

He said the company “thought that the economy and the business were going to go in in a certain direction” based on positive indicators relating to e-commerce businesses during the height of the COVID-19 pandemic in 2021. “Obviously it hasn't turned out that way,” Zuckerberg added.

“Our kind of operational focus over the next few years is going to be on efficiency and discipline and rigor and kind of just operating in a much tighter environment.”

Despite the apparent focus from Meta to build its metaverse, Zuckerberg claimed 80% of company investments are funneled into its flagship social media platforms and will continue that way “for quite some time.”

Investments in Reality Labs are “less than 20%” at least “until the Metaverse becomes a larger thing” he said.

Related: The metaverse is happening without Meta's permission

Of the 20% invested in Reality Labs, Zuckerberg said 40% of it goes toward its Virtual Reality (VR) headsets with the other “half or more” building what he considers “the long-term most important form factor [...] Normal-looking glasses that can put holograms in the world.”

Zuck takes bite at Apple

Zuckerberg also took a few jabs at its peer tech company Apple regarding its restrictive App Store policies, the likes of which have placed restrictions on crypto exchanges and nonfungible token (NFT) marketplaces, saying:

“I do think Apple has sort of singled themselves out as the only company that is trying to control unilaterally what apps get on a device and I don't think that's a sustainable or good place to be.”

He pointed to other computing platforms such as Windows and Android which are not as restrictive and even allow other app markets and sideloading — the use of third-party software or apps.

He added its been Meta’s commitment to allow sideloading with its existing VR units and upcoming Augmented Reality (AR) units and hoped the future Metaverse platforms were also open in such a manner.

“I do think it is it is problematic for one company to be able to control what kind of app experiences get on the device.”

Read More

Continue Reading

Uncategorized

Nifty News: Porsche 911 NFTs, BMW files Web3 trademarks, Baby Shark’s NFT game and more…

BMW and Porsche have both recently ramped up their own Web3 plays, while Baby Shark is dipping into the blockchain gaming sector, but just for kids.

Published

on

BMW and Porsche have both recently ramped up their own Web3 plays, while Baby Shark is dipping into the blockchain gaming sector, but just for kids.

Porsche to launch 7,500 NFTs for use in a ‘virtual world’

German luxury car manufacturer Porsche has suggested it will be significantly ramping up its Web3 efforts after unveiling an upcoming NFT project consisting of 7,500 customizable tokenized vehicles.

In a Nov. 29 announcement, Porsche stated that the NFTs will be launched in January, and users will be able to customize various aspects of the cars in relation to performance and appearance.

The NFT art itself is being designed by designer and 3D artist Patrick Vogel, with all pieces revolving around the famous Porsche 911 model.

Notably these virtual assets will be designed in Epic Games’ Unreal Engine 5, suggesting that gaming integrations are afoot.

NFT car designs: Porsche

The company gave a sneak peek into the project at the Art Basel conference in Miami on Nov. 30. While specific details have not been mentioned, the company noted that owners will be able to use the cars in the “virtual world,” most likely meaning some sort of Metaverse.

More broadly, Porsche suggested that it is looking to significantly ramp up its exposure to Web3 moving forward, with the announcement noting that:

“Digital art is just one aspect of Porsche’s Web3 strategy. The sports car manufacturer is working to integrate the potential of blockchain technology into existing and future processes and solutions.”

Porsche previously had a hand in launching soccer-themed NFT collectibles in June 2021 as part of a project called Fanzone, but now appears to be taking the tokenization of its cars more seriously.

BMW to get Web3 trademarks

Speaking of German luxury car manufacturers, BMW has reportedly applied to trademark its logo in relation to a host of Web3 products and services.

The move was highlighted by USPTO licensed trademark attorney Mike Kondoudis, who frequently shares news regarding Web3 trademark applications in the U.S. from major companies.

BMW outlined intentions for its logo to span across collectibles such as virtual clothing, footwear, headwear and vehicles, while also indicating plans for downloadable virtual goods such as online environments and games.

Baby Shark’s Web3 arc

Content from Pinkfong’s massively popular children’s song/music video Baby Shark is set to be tokenized as part of a family-focused blockchain game.

Pinkfong reportedly penned a licensing agreement with Toekenz Collectibles to create and issue Baby Shark characters in a child safe digital environment.

Baby Shark NFT partnership: Toekenz

Toekenz Collectibles is an NFT platform targeted at children aged 12 and under, and the focus of the game is to educate kids aged five to nine “about the trading economy of digital collectibles.”

The kids will also be able to customize the NFT art to their own liking, and even participate in a Tokenz DAO where they “can exercise democratic decision-making.”

This is not Pinkfong’s first dip into NFTs, Cointelegraph previously reported that the South Korea-based company launched a series of limited editions Baby Shark NFTs in December last year.

Related: Two Bored Apes sell for $1M each: Nifty Newsletter, Nov. 23–29

Deadmau5 rolling out music metaverse

A Web3 startup co-founded by popular crypto-friendly DJ Deadmau5 (Joel Zimmerman) is gearing up for the launch of a music and gaming focused Metaverse platform.

Announced at the Art Basel event on Nov. 29, the start-up known as Pixelynx stated that the Polygon-based platform will launch this week, and kick things off with an Augmented Reality (AR) scavenger hunt set on Miami Beach.

The firm’s CEO and co-founder Inder Phull described the AR scavenger hunt as a “Rock Band meets Pokémon Go experience,” in which virtual gaming features are merged with real locations on maps via smart devices.

Users who hold Deadmau5’s Droplet NFTs will gain early access to Pixelynx’s metaverse with the platform aiming to provide a host of virtual experiences for fans of particular musicians and artists.

More Nifty News

NFTs depicting the ongoing protests in China against the country’s tough zero-tolerance COVID-19 policy have found their way to the NFT marketplace OpenSea at the tail end of November.

On Nov. 30, decentralized exchange (DEX) Uniswap announced that users can now trade NFTs on its native protocol. The function will initially feature NFT collections for sale on platforms including OpenSea, X2Y2, LooksRare, Sudoswap, Larva Labs, X2Y2, Foundation, NFT20, and NFTX.

Read More

Continue Reading

Trending